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Purpose: To develop an ibuprofen ointment with a potential for both topical and systemic delivery of the 
drug. 
Method: A co-solvency technique with a trial and error approach was used to develop a 10% ibioprofen 
ointment in petrolatum base, with the entire drug dissolved in the base. An insertion cell was used to 
evaluate drug release from the formulations. Further, factorial design multiple regression (FDMRA) 
analysis, a statistical optimization technique, was used in the optimization of the final formulation.  
Result: The desired ibuprofen ointments were developed. Release depended on vehicle and proportion 
of co-solvents. Best fit equations for optimization purposes including various fluxes (initial, steady-state 
and total) and diffusion coefficient as dependent variables and the concentrations of co-solvents as 
independent variables were obtained using SAS programme. Dependent variables strongly depended 
(p<0.05) on the independent variables and followed the polynomial equations generated.  
Conclusion: The ointments consisting of petrolatum base (80%), PEG 400 (6%) and propylene glycol 
(4%) and ibuprofen (10%) and that consisting of petrolatum base (75%), PEG 400 (6%), propylene 
glycol (4%), menthol (5%) and ibuprofen (10%) can be used for topical and systemic delivery of the 
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INTRODUCTION 
The delivery of drug through the skin has long 
been a promising concept because of the ease 
of access, large surface area, vast exposure to 
the circulatory and lymphatic networks, and non-
invasive nature of the treatment1, This is true 
whether the bioavailability desired is systemic or 
local.  
 
A 5% ibuprofen cream and a 5% gel are  
available in the market. Recently, a 10% 
ibuprofen gel and a 15% ibuprofen cream have 
been introduced, with the advantage of quicker 
release. However, as a result of the aqueous 
nature of the base, ibuprofen precipitation may 
occur in the gels. Also, it cannot be used on 
open wounds.   It is for these reasons that we 
developed a petrolatum ointment of ibuprofen 
Manufacturers produce high quality, petrolatum, 
hence the choice of petrolatum is the vehicle in 
this study. Besides, petrolatum as occlussive 
and has been found to increase the skin 
permeability of several drugs1. Interestingly, 
ibuprofen can be conveniently solubilized in the 
petrolatum, which could be a constraint with gels 
and creams. In this study, we aimed at improving 
therapy by enhancing the local and systemic 
delivery of ibuprofen, a non-steroidal anti-
inflammatory drug (NSAID) using an ointment 
preparation. NSAIDS are commonly used as 
topical analgesic/antirheumatic agents2, 3 
because of the decrease in the incidence of 
side-effects associated with systemic delivery.  
Literature data clearly indicates that ibuprofen 
can conveniently reach systemic circulation after 
topical application4 but therapeutic blood levels 
of the drug may not be achieved at the low drug 
concentration of 5%w/w in the ointment. 
The objectives of the study is two-fold, First, to 
develop a 10% ibuprofen ointment with a high 
skin permeability of the drug.  Second, to 
develop a theoretical relationship that may be 
used to optimize the ointment formulation. 
 
 
MATERIALS AND METHODS 
Ibuprofen was obtained from Boots India Ltd., 
Mumbai. White beeswax and hard paraffin were 
purchased from Loba Chemic, Mumbai. White 
soft paraffin was purchased from Burgoyn 
Urbidges & Co., Mumbai. Polyethylene glycol 
400, propylene glycol and menthol were 
obtained from S.D. Fine Chemicals, Bombay. 
Methanol was procured from Ranbaxy 
Chemicals, Delhi. To conduct release studies, 
magnetic stirrers from Remi Equipments Pvt. 
Limited and a dialysis membrane -70 obtained 
from Himedia was used. An SL 164 Elico Double 
Beam UV-Vis Spectrophotometer was used to 
analyze the samples. A diffusion cell (designed 
in our laboratory) was used for drug release 
study. Excel and SAS applications used in the 
studies were obtained from Microsoft (Redmond, 
WA, USA) and SAS Institute (Cary, NC, USA), 
respectively. 
 
Preparation of the ointments 
Paraffin ointment was prepared by melting 
together white bees wax, hard paraffin, 
polyethylene glycol or propylene glycol or 
menthol on a hot plate/stirrer (at 70ºC). Drug 
was added to this molten base while stirring. The 
entire mixture was stirred while cooling to form 
Ibuprofen ointment. Various compositions of the 
ointments were prepared for evaluation.   
 
Estimation of drug solubility  
To determine the solubility of the drug in the 
ointment base, a new technique based on 
microscopic evaluation was developed in our 
laboratory. According to this method, an 
ointment base was selected and the drug in the 
increasing concentrations was dissolved in the 
base.  At the end of ointment preparation, a 
small aliquot was placed on to a glass slide with 
a cover slip and the number of crystals 
remaining in one field was determined. Readings 
from at least 10 fields was considered. A plot of 
concentration against the number of crystals. 
Resulted in a straight line. The solubility of the 
drug in the ointment base was considered  as 
the intercept on the concentration axis.  
 
Influence of PEG and propylene glycol on  
ibuprofen solubility  
Petrolatum bases containing varying  proportions 
of PEG 400 and propylene glycol were made. 
The solubility of ibuprofen in these ointment 
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bases was determined using the solubility 
method described in the preceding section. 
 
Membrane permeability measurement  
Drug release measurements were carried out in 
a diffusion cell designed in our laboratory. An 
inverted cylindrical test tube cut to a height of 8 
cm was used as a donor cell. The receptor 
chamber cell consisted of a beaker containing 
100 ml of water. A dialysis membrane soaked in 
warm water for 30 minutes was placed at the 
lower end of the cylindrical portion. 500 mg of 
ointment was placed in this chamber and this 
was inserted into the receptor chamber such that 
the height was sufficient for the drug to be 
released into the receptor. The receptor 
chamber was placed on a magnetic stirrer and 
mixed at a uniform speed. Samples were drawn 










































































     Table 2 SAS Program used in the optimization 
 
 
  DATA REGRESSN; 
  INPUT X1 X2 Y; 
  X11=X1**2; X22=X2**2;X12=X1*X2; 
DATALINES; 
3 3 y1 
3 4 y2 
3 5 y3 
4 3 y4 
4 4 y5 
4 5 y6 
5 3 y7 
5 4 y8 
5 5 y9 
; 
PROC REG DATA=REGRESSN; 
  TITLE ‘DRUG RELEASE’; 




Note: In the above data lines, y1, y2……y9 are the numbers 
associated with the dependent variable. For each of the dependent 
variable, the same program as mentioned above is written and the 
output  was obtained by running the program. 
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at predetermined time intervals. The samples 
were assayed for drug content 
spectrophotometer at λmax–nm.  Cumulative 
amount of drug permeated vs. time (zero order 
plot) and vs the square root of time (Higuchi plot) 
were constructed.  The Higuchi plot fitted more 
and hence was used in the calculation of the 
diffusion coefficients applying the Higuchi 
equation5. 
Q = 2C0(Dt/π)1/2   …………… eqn 1 
Where C0  is the initial drug concentration in the 
donor, ‘Q’ is the cumulative amount of drug 
released at time ‘t’ and ‘D’ is the diffusion 
coefficient. 
 
Optimization of drug release 
In the present study, the amount of propylene 
glycol and menthol in the ointments were 
selected as independent variables, whereas 
initial flux, steady state flux, total flux and 
diffusion coefficients were selected as 
dependent variables. These factors are known to 
influence the topical and systemic bioavailability 
of drugs from topical preparations. The factors 
were selected in a 32 factorial design, giving a 
total of  nine different ointment formulations 
designed forms to Ibuprofen concentration in all 
the ointments was kept at 10% while the 
concentration of PEG 400 was also kept 
constant at 6% (see Table 1).   
The initial and the steady state fluxes were 
calculated using the cumulative amount released  
vs time plot.  When the plot of amount released 
vs square root of time gave a straight line, then 
diffusion coefficient was calculated using the 
Higuchi equation. Factorial design – multiple 
regression analysis (FD-MRA) was performed 
using SAS programme. The SAS programme 
selected gave the regression equation (Eq. 2), 
R-value and F-value along with the predicted 
numbers for the dependent variables. Surface 
contours were plotted with Excel software using 
the predicted numbers.  The SAS Programme 
for the assessment of the relationship between 
dependent and independent variables is shown 
in Table 2. 
 
RESULTS 
As the concentration of propylene glycol and 
PEG 400 increased, there was an increase in 
the solubility of the drug in the ointment. 
Ibuprofen solubility in Forms 1, 2, 3, 4, and 5 
were (%w/v): 5.8, 6.5, 6.75, 7.6 and 10.5, 
respectively. Form 5 was, therefore, the final 
topical ointment base and  contained 10% drug 
in the soluble form, 6% PEG 400, 4% propylene 
glycol and the rest, petrolatum base. 
Formulations with high menthol content, up to 
10%, can be used for systemic delivery of the 
drug, as menthol is a known skin permeation 
enhancer. The ointments were characterized for 
the drug release. (Fig 1).   The Higuchi plot 
yielded a straight line for all the ointment 
formulations.  The diffusion coefficients of the 
drug from the various ointment bases was 
determined using the Higulchi model and the 
values are presented in Fig 2.  The SAS output 
of the FD-MRA gave several statistics which 
could be used in the interpretation of the model. 
The analysis further gave predicted numbers for 
the experimental numbers. From the SAS 
output, a high drug release was associated with 
both the concentration of propylene glycol (X1) 
and menthol (X2).  All the dependent variables 
namely, initial flux, steady state flux, flux and the 
diffusion coefficients produced strong 
correlation. The model used in the SAS 
programme gave good results (SAS output not 
presented here). Two-dimensional contour plots 
were established with predicted numbers using 
Excel. SAS was used to generated best fit 
equations for the initial flux, steady state flux, 
flux and the diffusion coefficients. The common 
equation for the dependent variable is as shown 
in Eq 3. 
 
Y = A0 + A1X1 + A2X2 + A3X12 + A4X22 + A5X1X2 ……….(3) 
 
The coefficients, R-2 values, F-value and p value 






In this study, we aimed firstly at the development 
of a 10% ibuprofen ointment with a potential for 
enhanced transdermal delivery. The estimated 
concentrations after epidermal applications of 
NSAID can be related to their flux across the 
epidermis from an applied vehicle6, flux being 
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directly proportional to the tissue concentration 
 
Table 3: Optimization parameters obtained using SAS Programme  
 
 A0 A1 A2 A3 A4 A5 R2 Fvalue Pr>F 
I. Flux 1195 561 -934 21 -76 109 0.95 11.49 0.036 
S. Flux -412 453 -106 -14 -47 19 0.98 36.10 0.007 
Flux -193 499 -250 -11 -54 36 0.98 37 0.007 
Dx10-7 -3.22 5.64 -3.12 -0.086 -0.63 0.44 1.00 181 0.006 
 





















































Figure 2: Diffusion coefficient of the ibuprofen from various ointment bases 
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of the drug6. Our preliminary study with 5% and 
10% ibuprofen in petrolatum base gave similar 
results.  The high drug release from the 
formulation containing 10% of the drug is 
therefore, an indication that the topical 
application of this formulation will achieve high 
tissue concentrations of the drug.  The basis 
being that high drug release from the ointment 
base is associated with high skin permeability, 
provided that drug partitioning into the skin is not 
a problem.  Enhanced release of drugs has also 
been achieved by supersaturation of the 
ointment base.  In this study, we successfully 
employed a co-solvency technique to achieve 
the same results.   
The second aim of this investigation was to 
statistically optimize the formulation. The FD-
MRA technique has been used previously to 
statistically optimize the formation of ointments.  
The two factors evaluated were the 
concentrations of propylene glycol and menthol.  
It has also been shown that the four different 
dependent variables have strong influence on 
topical and systemic effects8 are the initial flux, 
steady-state flux, flux and diffusion coefficient. 
The outcome of this study was consistent with 
the previous finding. All the equations fit into the 
SAS programme and demonstrated statistical 
strength (p<0.05).  Thus, the response surface 
based optimisation scheme could be used for 
the evaluation of direction of formulation 
development. This type of optimisation approach 
has also been applied to liposome formulation9.  
 
CONCLUSION       
The results of the study clearly indicate that 
transdermal formulations of ibuprofen 
(ointment/patch) are possible. Using a co-
solvency technique, the soluble drug 
concentration in the ointment can be enhanced 
to 10%.  The addition of a penetration enhancer, 
menthol, in the ointment will be expected to 
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